US Stock Futures Edge Higher Ahead Of Jobless Claims Report

November 18, 2015

21

US Stock Futures Edge Higher Ahead Of Jobless Claims Report

Pre-open movers

US stock futures traded higher in early pre-market trade. Data on weekly jobless claims will be released at 8:30 a.m. ET, while leading indicators index for October will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average surged 8 points to 17,697.0, while the Standard & Poor’s 500 index futures rose 3.75 points to 2,083.50. Futures for the Nasdaq 100 index gained 11.50 points to 4,664.00.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 1.01 percent, STOXX Europe 600 Index surging 0.92 percent and German DAX 30 index gaining 1.53 percent. French CAC 40 Index surged 0.75 percent and London’s FTSE 100 Index rose 1.28 percent.

In Asian markets, Japan’s Nikkei Stock rose 1.07 percent, Hong Kong’s Hang Seng Index climbed 1.41 percent, China’s Shanghai Composite Index jumped 1.36 percent and India’s BSE Sensex rose 1.41 percent.

Broker Recommendation
Analysts at Longbow Research downgraded Lennox International Inc. (NYSE: LII) from Buy to Neutral.

Lennox International shares rose 1.92 percent to close at $136.74 yesterday.

Breaking news

J M Smucker Co (NYSE: SJM) reported better-than-expected earnings for its fiscal second quarter on Thursday. To read the full news, click here.
Spectrum Brands Holdings, Inc. (NYSE: SPB) reported weaker-than-expected results for the third quarter. To read the full news, click here.
Eli Lilly and Co (NYSE: LLY) and Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, today announced the extension of an existing collaboration to evaluate the safety and efficacy of the combination of Lilly’s ALIMTA(R) (pemetrexed for injection) and Merck’s KEYTRUDA(R) (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC). To read the full news, click here.
Shares of Keurig Green Mountain Inc (NASDAQ: GMCR) jumped around 18 percent in pre-market trading after the company reported upbeat results for its fiscal fourth quarter and lifted its dividend. To read the full news, click here.